Transplant Diagnostics Market Report on the Untapped Growth Opportunities in the Industry

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (hospitals & Transplant services, research & academic institutes, and independent reference laboratories.)- Market Outlook And Industry Analysis 2034"

The Global Transplant Diagnostics Market is estimated to reach over USD 10.4 Bn by 2034, exhibiting a CAGR of 7.9% during the forecast period.

Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1760

The global Transplant Diagnostics Market is experiencing strong growth, fueled by several key factors. Among these are the increasing use of stem cell therapies, soft tissue and organ transplants, the rising prevalence of chronic illnesses, and ongoing advancements in laboratory automation and diagnostic robotics. Notably, progress in Human Leukocyte Antigen (HLA) typing technologies has also played a pivotal role in enhancing diagnostic accuracy and efficiency.

Investment in the development of advanced HLA testing products, both from public and private sectors, continues to rise. In parallel, the adoption of Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) instruments is expanding, contributing to a more robust diagnostic ecosystem. The cost of gene sequencing has also dropped significantly, making these technologies more accessible across global healthcare systems, especially in developing countries where improvements in medical infrastructure are accelerating.

List of Prominent Players in the Transplant Diagnostics Market:
• Abbott Laboratories, Inc.
• Adaptive Biotechnologies
• Affymetrix, Inc.
• altona Diagnostics GmbH
• Arquer Diagnostics Ltd
• BAG Diagnostics GmbH
• Becton, Dickinson and Company,
• Biofortuna Limited
• BioMerieux SA,
• Bio-rad Laboratories, Inc.
• Biotype GmbH
• Bruker,
• CareDx Inc.
• CLONIT srl
• Diagnóstica Longwood SL
• DiaSorin S.p.A.
• ELITechGroup
• EUROFINS VIRACOR
• F. Hoffmann La-Roche AG.
• Hologic, Inc.
• Horiba Ltd
• Illumina, Inc.
• Immucor Transplant Diagnostics, Inc.
• Laboratory Corporation of America Holdings.
• Linkage Biosciences
• Luminex Corporation
• Merck KGaA
• NanoString
• Olerup SSP AB
• Omixon Ltd.
• PathoNostics
• Preservation Solutions, Inc.
• Qiagen N.V.
• Randox Laboratories Ltd.
• Stryker
• Takara Bio Inc.
• Thermo Fisher Scientific,
• TransMedics
• Transonic
• Zimmer Biomet

Market Dynamics:
Drivers-
The growing incidence of organ failure due to acute and chronic diseases is a major factor propelling the transplant diagnostics market. As the number of patients requiring organ transplants continues to rise, so does the need for accurate compatibility testing to ensure transplant success. Diagnostic tests help determine whether a recipient's immune system will accept a donor organ, which is a critical component of the transplant process. In the United States, the demand for organ transplants reached a peak in 2021. According to the United Network for Organ Sharing (UNOS), there were 3,817 heart transplants, 24,669 liver transplants, and 9,236 kidney transplants that year.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1760

Challenges:
Despite rising demand, a significant gap persists between the number of patients needing transplants and the availability of donor organs. According to the Health Resources and Services Administration, over 106,000 individuals were on the national transplant waiting list in 2021.

Regional Trends:
Globally, the transplant diagnostics market is segmented into six key regions: North America, Latin America, Europe, Asia Pacific, the Middle East & Africa, and the Rest of the World. North America leads the market, supported by an established infrastructure for organ transplantation, increasing stem cell applications, financial support for HLA typing innovation, and the gradual reduction in gene sequencing costs. Meanwhile, the Asia Pacific region-particularly China and India-is anticipated to experience the fastest growth over the next five years, driven by an expanding healthcare infrastructure, rising disease prevalence, and growing awareness of organ transplant procedures.

Recent Developments:
• In March 2022, Immucor, Inc., a business specialising in transfusion and transplantation diagnostics, introduced two new products to its transplant diagnostics line, proving its dedication to recent developments in the histocompatibility industry.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1760

Segmentation of Transplant Diagnostics Market-
By Technology-
• Molecular assay technologies
o PCR based molecular assays
o Real-time PCR
o Sequence-specific primer-PCR
o Sequence-specific Oligonucleotide-PCR
o Other PCR-based molecular assays
• Sequencing based molecular assays
o Sanger sequencing
o Next generation sequencing
o Others
• Non molecular assays technologies
By Product & Service-
• Reagents & Consumables
• Instruments
• Software & Services
By Application-
• Diagnostic Application
o Pre-Transplantation
 Infectious Disease Testing
 Histocompatibility Testing
 Blood Profiling
o Post-Transplantation Diagnostics
• Research Applications
By Transplant Type-
• Solid organ transplantation
o Kidney
o Liver
o Heart
o Lung
o Pancrease
o Others
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation
By End-User-
• Hospitals & Transplant Centers
• Research & Academic Institutes
• Independent Research Laboratories
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get More Information: @
https://www.insightaceanalytic.com/report/transplant-diagnostics-market/1760

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.